Japanese Encephalitis Vaccine • ixiaro
£115 per dose / £230 total course
What is Japanese encephalitis
Japanese encephalitis is a viral disease which, like malaria, is transmitted by mosquitoes. In many patients, Japanese encephalitis symptoms remain mild and the infection may even go unnoticed. However, in some cases, the virus causes severe symptoms and leads to serious complications.
Typical encephalitis symptoms include nausea and vomiting, seizures, headaches, and confusion. The Japanese encephalitis virus affects the human brain and can lead to inflammation and swelling in the brain. In very severe cases, the infection can lead to brain damage.
There is no specific medication to treat and cure this type of encephalitis. Treatment usually focuses on relieving symptoms and supporting the immune system in its effort to fight the virus. A Japanese encephalitis vaccine provides medical protection for travelers at risk of catching the virus.
The World Health Organisation states, that there are roughly 70,000 new cases of Japanese Encephalitis worldwide each year. Half of these cases were in China, and around three-quarters of all cases were children under the age of 15 years.
If you have any queries please email firstname.lastname@example.org or call
020 7586 9668
COURSE/WHEN TO DO IT?
HOW LONG DOES IT LAST/WHEN IS BOOSTER NEEDED?
- You need to get the first dose ideally five weeks before you travel in order to be able to complete the course in time.
- The course consists of two doses. The second dose needs to be given ideally 28 days after the first. You are protected from seven days after the second dose.
- In special cases, you can get a faster course where the first dose should be at least 2 weeks before you travel.
- The vaccine protects you for at least 12 months, so you need a booster 12-24 months later to remain protected after one year.
HOW IS IT GIVEN?
Injection in the upper arm.
The vaccine can cause side effects such as digestive problems, a high temperature, and muscle pain.
You may also notice soreness at the injection site.